In a large cohort of young women, drospirenone did not cause a clinically significant increase in risk for hyperkalemia when compared with other progestin-containing OCs. It is however concerning ...

[5] The primary objective of the current study is to investigate the association between drospirenone and the diagnosis of hyperkalemia in a large unselected population. A secondary objective is ...